GearJump Technologies is an R&D company specializing in multidisciplinary engineering and life sciences to develop diagnostic and controlled drug delivery platforms for public health, agriculture, and vector control applications.
GearJump Technologies is a research and development company that creates novel diagnostic and controlled drug delivery platforms for applications in healthcare, agriculture, and vector control. Founded in 2011 and based in Brookline, Massachusetts, the firm leverages a multidisciplinary approach that combines expertise in bionanotechnology, materials science, microsystems, clinical medicine, and fluid mechanics. The company develops advanced technology solutions across various scales, ranging from nanoparticles to wearable personal protection devices, autonomous field-use devices, and drone-based deployment systems. Its platforms are engineered to optimize the delivery of active ingredients, such as pesticides or repellents, to improve efficacy and reduce environmental toxicity, with a focus on addressing challenging global problems that affect humans, animals, and plants.
The organization’s work is driven by a problem-centric methodology that identifies unmet needs before applying fundamental physics and engineering processes to design scalable, cost-effective solutions. GearJump Technologies collaborates with research institutions, industry leaders, government agencies, and non-profit organizations, including support from the Bill & Melinda Gates Foundation, to develop technologies that mitigate the burden of diseases and agricultural pests. Their solutions are currently involved in field trials across multiple continents, including North America, Latin America, Africa, Australia, and South East Asia, demonstrating the company’s commitment to achieving significant social impact through disruptive technological innovation.